Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
65
SJ.TO Quote, Financials, Valuation and Earnings
Last price:
$98.42
Seasonality move
:
11.15%
Day range:
$95.79 - $98.53
52-week range:
$62.26 - $99.60
Dividend yield:
1.27%
P/E ratio:
16.04x
P/S ratio:
1.56x
P/B ratio:
2.60x
Volume:
100.8K
Avg. volume:
117.9K
1-year change:
42.33%
Market cap:
$5.4B
Revenue:
$3.5B
EPS (TTM):
$6.10
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.8B | $3.1B | $3.3B | $3.5B | |
| Revenue Growth (YoY) | 16.54% | 7.8% | 11.46% | 8.29% | 4.52% | |
| Cost of Revenues | $2.1B | $2.3B | $2.6B | $2.6B | $2.8B | |
| Gross Profit | $432M | $445M | $509M | $673M | $709M | |
| Gross Profit Margin | 16.94% | 16.18% | 16.61% | 20.28% | 20.44% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $125M | $127M | $157M | $181M | $206M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $111M | $116M | $142M | $166M | $191M | |
| Operating Income | $321M | $329M | $367M | $507M | $518M | |
| Net Interest Expenses | $25M | $23M | $33M | $68M | $88M | |
| EBT. Incl. Unusual Items | $284M | $303M | $326M | $431M | $415M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $74M | $76M | $85M | $105M | $96M | |
| Net Income to Company | $210M | $227M | $241M | $326M | $319M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $210M | $227M | $241M | $326M | $319M | |
| Basic EPS (Cont. Ops) | $3.12 | $3.49 | $3.93 | $5.62 | $5.66 | |
| Diluted EPS (Cont. Ops) | $3.12 | $3.49 | $3.93 | $5.62 | $5.66 | |
| Weighted Average Basic Share | $67.3M | $65M | $61.4M | $58M | $56.4M | |
| Weighted Average Diluted Share | $67.3M | $65M | $61.4M | $58M | $56.4M | |
| EBITDA | $397M | $403M | $456M | $616M | $648M | |
| EBIT | $321M | $329M | $367M | $507M | $518M | |
| Revenue (Reported) | $2.6B | $2.8B | $3.1B | $3.3B | $3.5B | |
| Operating Income (Reported) | $321M | $329M | $367M | $507M | $518M | |
| Operating Income (Adjusted) | $321M | $329M | $367M | $507M | $518M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $679M | $842M | $949M | $915M | $958M | |
| Revenue Growth (YoY) | -8.49% | 24.01% | 12.71% | -3.58% | 4.7% | |
| Cost of Revenues | $599M | $706M | $738M | $730M | $774M | |
| Gross Profit | $80M | $136M | $211M | $185M | $184M | |
| Gross Profit Margin | 11.78% | 16.15% | 22.23% | 20.22% | 19.21% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $30M | $41M | $48M | $53M | $51M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $28M | $38M | $44M | $50M | $47M | |
| Operating Income | $52M | $98M | $167M | $135M | $137M | |
| Net Interest Expenses | $5M | $10M | $17M | $23M | $18M | |
| EBT. Incl. Unusual Items | $46M | $88M | $149M | $107M | $117M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12M | $23M | $39M | $27M | $29M | |
| Net Income to Company | $34M | $65M | $110M | $80M | $88M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $34M | $65M | $110M | $80M | $88M | |
| Basic EPS (Cont. Ops) | $0.53 | $1.07 | $1.91 | $1.42 | $1.59 | |
| Diluted EPS (Cont. Ops) | $0.53 | $1.07 | $1.91 | $1.42 | $1.59 | |
| Weighted Average Basic Share | $64.7M | $60.7M | $57.7M | $56.3M | $55.2M | |
| Weighted Average Diluted Share | $64.7M | $60.7M | $57.7M | $56.3M | $55.3M | |
| EBITDA | $70M | $119M | $194M | $167M | $173M | |
| EBIT | $52M | $98M | $167M | $135M | $137M | |
| Revenue (Reported) | $679M | $842M | $949M | $915M | $958M | |
| Operating Income (Reported) | $52M | $98M | $167M | $135M | $137M | |
| Operating Income (Adjusted) | $52M | $98M | $167M | $135M | $137M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.9B | $3.3B | $3.4B | $3.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.3B | $2.5B | $2.7B | $2.7B | $2.8B | |
| Gross Profit | $464M | $464M | $646M | $708M | $685M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $127M | $145M | $181M | $200M | $206M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $115M | $132M | $164M | $185M | $191M | |
| Operating Income | $349M | $332M | $482M | $523M | $494M | |
| Net Interest Expenses | $22M | $28M | $58M | $86M | $75M | |
| EBT. Incl. Unusual Items | $322M | $302M | $413M | $425M | $439M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $83M | $75M | $107M | $102M | $100M | |
| Net Income to Company | $239M | $227M | $306M | $323M | $339M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $239M | $227M | $306M | $323M | $339M | |
| Basic EPS (Cont. Ops) | $3.65 | $3.65 | $5.25 | $5.70 | $6.10 | |
| Diluted EPS (Cont. Ops) | $3.65 | $3.65 | $5.25 | $5.70 | $6.10 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $423M | $415M | $586M | $650M | $634M | |
| EBIT | $349M | $332M | $482M | $523M | $494M | |
| Revenue (Reported) | $2.7B | $2.9B | $3.3B | $3.4B | $3.5B | |
| Operating Income (Reported) | $349M | $332M | $482M | $523M | $494M | |
| Operating Income (Adjusted) | $349M | $332M | $482M | $523M | $494M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.6B | $2.7B | $2.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2B | $2.1B | $2.2B | $2.2B | -- | |
| Gross Profit | $402M | $539M | $574M | $551M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $113M | $137M | $156M | $156M | -- | |
| Other Inc / (Exp) | -- | -- | -- | $28M | -- | |
| Operating Expenses | $103M | $125M | $144M | $145M | -- | |
| Operating Income | $299M | $414M | $430M | $406M | -- | |
| Net Interest Expenses | $22M | $47M | $65M | $52M | -- | |
| EBT. Incl. Unusual Items | $276M | $363M | $357M | $381M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $71M | $93M | $90M | $94M | -- | |
| Net Income to Company | $205M | $270M | $267M | $287M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $205M | $270M | $267M | $287M | -- | |
| Basic EPS (Cont. Ops) | $3.31 | $4.64 | $4.72 | $5.17 | -- | |
| Diluted EPS (Cont. Ops) | $3.31 | $4.64 | $4.72 | $5.17 | -- | |
| Weighted Average Basic Share | $186.3M | $174.8M | $169.7M | $166.4M | -- | |
| Weighted Average Diluted Share | $186.3M | $174.8M | $169.7M | $166.5M | -- | |
| EBITDA | $362M | $492M | $526M | $512M | -- | |
| EBIT | $299M | $414M | $430M | $406M | -- | |
| Revenue (Reported) | $2.4B | $2.6B | $2.7B | $2.8B | -- | |
| Operating Income (Reported) | $299M | $414M | $430M | $406M | -- | |
| Operating Income (Adjusted) | $299M | $414M | $430M | $406M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $50M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $193M | $218M | $270M | $270M | $246M | |
| Inventory | $1.1B | $1.1B | $1.2B | $1.6B | $1.8B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $36M | $43M | $58M | $48M | $42M | |
| Total Current Assets | $1.3B | $1.4B | $1.6B | $1.9B | $2.1B | |
| Property Plant And Equipment | $709M | $767M | $915M | $1.2B | $1.4B | |
| Long-Term Investments | -- | $3M | $29M | $21M | $21M | |
| Goodwill | $280M | $341M | $369M | $375M | $406M | |
| Other Intangibles | $115M | $158M | $171M | $169M | $170M | |
| Other Long-Term Assets | $3M | $8M | $6M | $5M | $8M | |
| Total Assets | $2.4B | $2.7B | $3.1B | $3.7B | $4.1B | |
| Accounts Payable | $55M | $57M | $157M | $152M | $127M | |
| Accrued Expenses | $61M | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $11M | $33M | $1M | $100M | $1M | |
| Current Portion Of Capital Lease Obligations | $33M | $35M | $41M | $54M | $64M | |
| Other Current Liabilities | $18M | $11M | $9M | $26M | $3M | |
| Total Current Liabilities | $218M | $242M | $259M | $384M | $286M | |
| Long-Term Debt | $701M | $810M | $1.1B | $1.5B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.2B | $1.5B | $2.1B | $2.2B | |
| Common Stock | $214M | $208M | $194M | $189M | $188M | |
| Other Common Equity Adj | $80M | $79M | $171M | $134M | $255M | |
| Common Equity | $1.4B | $1.4B | $1.6B | $1.7B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.4B | $1.4B | $1.6B | $1.7B | $1.9B | |
| Total Liabilities and Equity | $2.4B | $2.7B | $3.1B | $3.7B | $4.1B | |
| Cash and Short Terms | -- | -- | -- | -- | $50M | |
| Total Debt | $745M | $878M | $1.1B | $1.6B | $1.7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $69M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $284M | $325M | $400M | $370M | $398M | |
| Inventory | $1.1B | $1.1B | $1.4B | $1.6B | $1.6B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $43M | $76M | $67M | $55M | -- | |
| Total Current Assets | $1.4B | $1.5B | $1.9B | $2B | $2.1B | |
| Property Plant And Equipment | $729M | $863M | $1.1B | $1.3B | $1.4B | |
| Long-Term Investments | -- | $32M | $30M | $16M | $12M | |
| Goodwill | $280M | $368M | $383M | $382M | -- | |
| Other Intangibles | $119M | $164M | $173M | $164M | -- | |
| Other Long-Term Assets | $6M | $6M | $5M | $7M | -- | |
| Total Assets | $2.5B | $2.9B | $3.6B | $3.9B | $4B | |
| Accounts Payable | $214M | $211M | $242M | $192M | $172M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $33M | $1M | $103M | $1M | -- | |
| Current Portion Of Capital Lease Obligations | $44M | $41M | $48M | $60M | -- | |
| Other Current Liabilities | $11M | $11M | $19M | $26M | -- | |
| Total Current Liabilities | $317M | $272M | $434M | $298M | $288M | |
| Long-Term Debt | $602M | $893M | $1.2B | $1.5B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.4B | $1.9B | $2.1B | $2B | |
| Common Stock | $210M | $196M | $189M | $188M | $188M | |
| Other Common Equity Adj | $81M | $186M | $22M | $156M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.5B | $1.6B | $1.7B | $1.8B | $2.1B | |
| Total Liabilities and Equity | $2.5B | $2.9B | $3.6B | $3.9B | $4B | |
| Cash and Short Terms | -- | -- | -- | -- | $69M | |
| Total Debt | $679M | $935M | $1.4B | $1.6B | $1.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $210M | $227M | $241M | $326M | $319M | |
| Depreciation & Amoritzation | $76M | $74M | $89M | $109M | $130M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$32M | -$19M | -$43M | -$9M | $56M | |
| Change in Inventories | -$123M | -$21M | -$75M | -$353M | -$82M | |
| Cash From Operations | $178M | $251M | $255M | $107M | $408M | |
| Capital Expenditures | $55M | $64M | $108M | $165M | $143M | |
| Cash Acquisitions | -- | $129M | $46M | $93M | $4M | |
| Cash From Investing | -$54M | -$193M | -$154M | -$258M | -$137M | |
| Dividends Paid (Ex Special Dividend) | $40M | $47M | $49M | $53M | $63M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $20M | $372M | $202M | $395M | $568M | |
| Long-Term Debt Repaid | -$43M | -$276M | -$74M | -$51M | -$636M | |
| Repurchase of Common Stock | $60M | $108M | $180M | $142M | $90M | |
| Other Financing Activities | -$1M | $1M | -- | $2M | -- | |
| Cash From Financing | -$124M | -$58M | -$101M | $151M | -$221M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $50M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $50M | |
| Ending Cash (CF) | -- | -- | -- | -- | $100M | |
| Levered Free Cash Flow | $123M | $187M | $147M | -$58M | $265M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $34M | $65M | $110M | $80M | $88M | |
| Depreciation & Amoritzation | $18M | $21M | $27M | $32M | $36M | |
| Stock-Based Compensation | $68M | -- | -- | -- | -- | |
| Change in Accounts Receivable | $69M | $66M | $25M | $70M | $14M | |
| Change in Inventories | $81M | $56M | -$48M | $27M | $71M | |
| Cash From Operations | $225M | $193M | $130M | $186M | $198M | |
| Capital Expenditures | $14M | $23M | $44M | $38M | $21M | |
| Cash Acquisitions | -- | $8M | $52M | $4M | $10M | |
| Cash From Investing | -$13M | -$31M | -$96M | -$42M | -$30M | |
| Dividends Paid (Ex Special Dividend) | $11M | $12M | $13M | $15M | $17M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$11M | -$47M | $36M | -- | -- | |
| Long-Term Debt Repaid | -$163M | -$45M | -$13M | -$100M | -- | |
| Repurchase of Common Stock | $27M | $59M | $45M | $30M | $20M | |
| Other Financing Activities | -- | $1M | $1M | $1M | -- | |
| Cash From Financing | -$212M | -$162M | -$34M | -$144M | -$164M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $69M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $4M | |
| Ending Cash (CF) | -- | -- | -- | -- | $73M | |
| Levered Free Cash Flow | $211M | $170M | $86M | $148M | $177M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $239M | $227M | $306M | $323M | $339M | |
| Depreciation & Amoritzation | $74M | $83M | $104M | $127M | $140M | |
| Stock-Based Compensation | $68M | -$68M | -- | -- | -- | |
| Change in Accounts Receivable | $59M | -$22M | -$63M | $21M | $13M | |
| Change in Inventories | -$125M | $22M | -$299M | -$204M | $104M | |
| Cash From Operations | $234M | $279M | $95M | $283M | $513M | |
| Capital Expenditures | $68M | $85M | $153M | $153M | $124M | |
| Cash Acquisitions | -- | $137M | $123M | $12M | $58M | |
| Cash From Investing | -$68M | -$222M | -$276M | -$155M | -$149M | |
| Dividends Paid (Ex Special Dividend) | $45M | $49M | $52M | $60M | $67M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $297M | $158M | $390M | $312M | -- | |
| Long-Term Debt Repaid | -$295M | $4M | -$14M | -$280M | -- | |
| Repurchase of Common Stock | $123M | $172M | $143M | $102M | $80M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$166M | -$57M | $181M | -$128M | -$295M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $69M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $166M | $194M | -$58M | $130M | $389M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $205M | $270M | $267M | $287M | -- | |
| Depreciation & Amoritzation | $63M | $78M | $96M | $106M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$78M | -$98M | -$68M | -$111M | -- | |
| Change in Inventories | $61M | -$163M | -$14M | $172M | -- | |
| Cash From Operations | $285M | $125M | $301M | $406M | -- | |
| Capital Expenditures | $65M | $110M | $98M | $79M | -- | |
| Cash Acquisitions | $8M | $85M | $4M | $58M | -- | |
| Cash From Investing | -$73M | -$195M | -$92M | -$104M | -- | |
| Dividends Paid (Ex Special Dividend) | $37M | $40M | $47M | $51M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $63M | $251M | $168M | $78M | -- | |
| Long-Term Debt Repaid | -$97M | -$37M | -$266M | -$128M | -- | |
| Repurchase of Common Stock | $142M | $105M | $65M | $55M | -- | |
| Other Financing Activities | $1M | $1M | $1M | -- | -- | |
| Cash From Financing | -$212M | $70M | -$209M | -$283M | -- | |
| Beginning Cash (CF) | -- | -- | -- | $215M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $19M | -- | |
| Ending Cash (CF) | -- | -- | -- | $234M | -- | |
| Levered Free Cash Flow | $220M | $15M | $203M | $327M | -- | |
Get SJ.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SJ.TO
Sector
P/E ratio
16.04x
19.88x
PEG ratio
2.29x
-0.02x
P/B ratio
2.60x
1.85x
Price / LTM sales
1.56x
1.65x
Growth Metrics
SJ.TO
Sector
Revenue growth
4.7%
2.4%
Earnings growth
12.07%
--
Revenue (5-year growth)
9.65%
3.24%
Earnings forecast
$1.02
$0.03
Profitability
SJ.TO
Sector
Profitability FY 2024
$709M
--
Return on invested capital
9.38%
-9.18%
Return on assets
8.32%
-10.59%
Return on equity
17.27%
-9.79%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
4
Balance Sheet
SJ.TO
Sector
Total cash
$69M
$2.6M
Short term investments
--
$217K
Total assets
$4.1B
$16.7M
Long term debt
$1.5B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
